Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. FDA To Open India Office In December

This article was originally published in PharmAsia News

Executive Summary

NEW DELHI - U.S. FDA plans to step up scrutiny of drugs and food made in India for the U.S. market by setting up offices next month in the country after establishing three branches in China, according to U.S. officials
Advertisement

Related Content

U.S. FDA Commissioner Hamburg Promotes Regulatory Science Collaboration In China Visit
U.S. FDA’s International Offices To Be Fully Staffed By End Of Summer
FDA’s International Offices To Be Fully Staffed By End Of Summer
FDA Opens First Office In India, A “Portal” To The Agency
U.S. FDA Opens First Office In India, A “Portal” To The Agency
U.S. FDA Launches First Overseas Office in Beijing
After Ranbaxy and Caraco, U.S. FDA Cracks Down On Lupin, Finds Lapses At Its Mandideep Site
After Ranbaxy and Caraco, U.S. FDA Cracks Down On Lupin, Finds Lapses At Its Mandideep Site
After Ranbaxy, U.S. FDA Hauls Up Caraco Pharma for QC Issues; May Withhold Future Drug Approvals
U.S. FDA Action Drives Ranbaxy Into Red; Company May Buyout Manufacturing Sites To Recover Lost Ground
Advertisement
UsernamePublicRestriction

Register

SC067224

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel